Replies to post #30128 on Biotech Values

[DewDiligence]

>Merck [KGaA] may use this money to bid for IMCL<

Merck KG has such a lopsidedly favorable deal with IMCL on the marketing of Erbitux that I find it hard to see how Merck gains from paying a premium to acquire the company. JMHO, FWIW